Dr. Kim Branson  is Senior Vice President and Global Head of Artificial Intelligence & Machine Learning at GSK, where he leads a global team developing and applying AI methods that accelerate drug discovery and clinical development.

Prior to joining GSK in 2019, he served as Head of AI for Early Clinical Development at Genentech and previously co-founded multiple Silicon Valley health-tech startups. Dr. Branson earned degrees from the University of Adelaide, completed a PhD in Computational Drug Design at the University of Melbourne, and undertook post-doctoral training at Stanford University establishing a deep technical foundation at the intersection of machine learning, structural biology, and drug discovery.

A recognized thought leader in AI-driven healthcare innovation, Dr. Branson exemplifies the powerful convergence of artificial intelligence and pharmaceutical R&D. He is a frequent keynote speaker at global conferences and remains a leading voice in leveraging AI to transform the future of data-enabled medicine.